Literature DB >> 18565995

Retinal ganglion cells in diabetes.

Timothy S Kern1, Alistair J Barber.   

Abstract

Diabetic retinopathy has long been recognized as a vascular disease that develops in most patients, and it was believed that the visual dysfunction that develops in some diabetics was due to the vascular lesions used to characterize the disease. It is becoming increasingly clear that neuronal cells of the retina also are affected by diabetes, resulting in dysfunction and even degeneration of some neuronal cells. Retinal ganglion cells (RGCs) are the best studied of the retinal neurons with respect to the effect of diabetes. Although investigations are providing new information about RGCs in diabetes, including therapies to inhibit the neurodegeneration, critical information about the function, anatomy and response properties of these cells is yet needed to understand the relationship between RGC changes and visual dysfunction in diabetes.

Entities:  

Mesh:

Year:  2008        PMID: 18565995      PMCID: PMC2614025          DOI: 10.1113/jphysiol.2008.156695

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  81 in total

1.  Systemic IGF-I treatment inhibits cell death in diabetic rat retina.

Authors:  Gail M Seigel; Sean B Lupien; Lorrie M Campbell; Douglas N Ishii
Journal:  J Diabetes Complications       Date:  2006 May-Jun       Impact factor: 2.852

2.  Dendritic abnormalities in retinal ganglion cells of three-month diabetic rats.

Authors:  Yaowu Qin; Gezhi Xu; Wenji Wang
Journal:  Curr Eye Res       Date:  2006-11       Impact factor: 2.424

3.  Rod photoreceptor dysfunction in diabetes: activation, deactivation, and dark adaptation.

Authors:  Joanna A Phipps; Peter Yee; Erica L Fletcher; Algis J Vingrys
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

4.  Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas.

Authors:  Matthew J Gastinger; Ravi S J Singh; Alistair J Barber
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

5.  Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.

Authors:  Timothy S Kern; Casey M Miller; Yunpeng Du; Ling Zheng; Susanne Mohr; Sherry L Ball; M Kim; Jeffrey A Jamison; David P Bingaman
Journal:  Diabetes       Date:  2007-02       Impact factor: 9.461

6.  Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy.

Authors:  Ling Zheng; Scott J Howell; Denise A Hatala; Kun Huang; Timothy S Kern
Journal:  Diabetes       Date:  2007-02       Impact factor: 9.461

7.  Diabetes-associated retinal nerve fiber damage evaluated with scanning laser polarimetry.

Authors:  Hirokazu Takahashi; Tomomi Goto; Takuhei Shoji; Masaki Tanito; Masami Park; Etsuo Chihara
Journal:  Am J Ophthalmol       Date:  2006-07       Impact factor: 5.258

8.  An electrophysiological study of retinal function in the diabetic female rat.

Authors:  David J Ramsey; Harris Ripps; Haohua Qian
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-11       Impact factor: 4.799

9.  Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia.

Authors:  Jason A Vincent; Susanne Mohr
Journal:  Diabetes       Date:  2007-01       Impact factor: 9.461

10.  Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.

Authors:  Azza B El-Remessy; Mohamed Al-Shabrawey; Yousuf Khalifa; Nai-Tse Tsai; Ruth B Caldwell; Gregory I Liou
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

View more
  164 in total

Review 1.  Inflammation in diabetic retinopathy.

Authors:  Johnny Tang; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2011-05-25       Impact factor: 21.198

2.  Early distal axonopathy of the visual pathway in experimental diabetes.

Authors:  Diego C Fernandez; Laura A Pasquini; Damián Dorfman; Hernán J Aldana Marcos; Ruth E Rosenstein
Journal:  Am J Pathol       Date:  2011-11-10       Impact factor: 4.307

3.  Induction of ischemic tolerance protects the retina from diabetic retinopathy.

Authors:  Diego C Fernandez; Pablo H Sande; Mónica S Chianelli; Hernán J Aldana Marcos; Ruth E Rosenstein
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 4.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

5.  Sirt1: A Guardian of the Development of Diabetic Retinopathy.

Authors:  Manish Mishra; Arul J Duraisamy; Renu A Kowluru
Journal:  Diabetes       Date:  2018-01-08       Impact factor: 9.461

6.  Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease?

Authors:  Renu A Kowluru; Qing Zhong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-07       Impact factor: 4.799

7.  Severity of diabetic retinopathy and health-related quality of life: the Los Angeles Latino Eye Study.

Authors:  Kashif Mazhar; Rohit Varma; Farzana Choudhury; Roberta McKean-Cowdin; Corina J Shtir; Stanley P Azen
Journal:  Ophthalmology       Date:  2010-10-29       Impact factor: 12.079

8.  Histone HIST1H1C/H1.2 regulates autophagy in the development of diabetic retinopathy.

Authors:  Wenjun Wang; Qing Wang; Danyang Wan; Yue Sun; Lin Wang; Hong Chen; Chengyu Liu; Robert B Petersen; Jianshuang Li; Weili Xue; Ling Zheng; Kun Huang
Journal:  Autophagy       Date:  2017-03-02       Impact factor: 16.016

9.  Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes.

Authors:  Moe H Aung; Han Na Park; Moon K Han; Tracy S Obertone; Jane Abey; Fazila Aseem; Peter M Thule; P Michael Iuvone; Machelle T Pardue
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

10.  Insulin treatment normalizes retinal neuroinflammation but not markers of synapse loss in diabetic rats.

Authors:  Dustin R Masser; Heather D VanGuilder Starkey; Georgina V Bixler; Wendy Dunton; Sarah K Bronson; Willard M Freeman
Journal:  Exp Eye Res       Date:  2014-06-12       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.